Implanon®: Insertion and Removal

  • Jeffrey P. Levine


The etonogestrel implant, Implanon® is a sterile 4-cm × 2-mm single rod that is implanted subdermally and can provide up to 3 years of continuous effective contraception. Each rod contains 68 mg of the progestin etonogestrel encased in an ethylene vinylacetate copolymer skin [1]. It is supplied in a sterile, preloaded disposable applicator. The applicator greatly facilitates proper insertion in a superficial plane, reduces the risk of infection via contamination of the sterile rod, and allows insertion without the need for incision and concomitant risk of scarring. Implanon® was approved by the US Food and Drug Administration in July 2006, but has already been used by over 5 million women worldwide.


Contraceptive Method Unintended Pregnancy Medial Epicondyle Sterile Gauze Antiseptic Solution 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Implanon® package insert. Organon USA Inc; Roseland, NJ; July 2006.Google Scholar
  2. 2.
    Levine JP. Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences. J Fam Pract 2004;53(11):904–913.PubMedGoogle Scholar
  3. 3.
    Amer College of Obstetricians and Gynecologists. ACOG Practice Bulletin No 73. Obstet Gynecol 2006;107:1453–1472.CrossRefGoogle Scholar
  4. 4.
    Wechselberger G, Wolfram D, Pulzl P, Soelder E, Schoeller T. Nerve injury caused by removal of an implantable hormonal contraceptive. Am J Obstet Gynecol 2006;195(1):323–326.PubMedCrossRefGoogle Scholar
  5. 5.
    Power J, French R, Cowan F. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy. Cochrane Database Syst Rev 2007;(3):CD001326.Google Scholar
  6. 6.
    Mascarenhas L. Insertion and removal of Implanon®. Contraception 1998;58(6 suppl):79S–83S.PubMedCrossRefGoogle Scholar
  7. 7.
    Klavon SL, Grubb GS. Insertion site complications during the first year of Norplant® use. Contraception 1990;41(1):27–37.PubMedCrossRefGoogle Scholar
  8. 8.
    Dunson TR, Amatya RN, Krueger SL. Complications and risk factors associated with the removal of Norplant® implants. Obstet Gynecol 1995;85(4):543–548.PubMedCrossRefGoogle Scholar
  9. 9.
    Shulman LP, Gabriel H. Management and localization strategies for the nonpalpable implanon® rod. Contraception 2006;73(4):325–330.PubMedCrossRefGoogle Scholar

Additional Resources Articles

  1. Levine JP. Insertion and removal of the single-rod progestin-only contraceptive implant. Female Patient 2006;suppl:26–30.Google Scholar

Web Sites

  1. Information about insertion and removal of Implanon® is available from the manufacturer by contacting Organon USA Inc at 1-877-467-5266 or

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Family MedicineUniversity of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical SchoolNew BrunswickUSA

Personalised recommendations